Overview of Pharmacovigilance 2021 - Overview of Pharmacovigilance Under COVID-19 Live Webinar
Topics/Call fo Papers
Pharmacovigilance Under COVID-19 course will provide an overview of the COVID constraints placed great strains upon the Pharmacovigilance reporting requirements as staff were working remotely or sick with the COVID illness.
For Pharmacovigilance and QA personnel, this course aims to demonstrate what the new guidances allow in terms of pharmacovigilance activities that can be relaxed during COVID and how to achieve these exemptions while achieving compliance and noting any deviations to existing processes and training.
Periodic reporting
Expedited reporting
What the EU Regulations are for COVID pharmacovigilance
Speaker:
With a first degree in Biochemistry & Pharmacology and a PhD focussing on drug metabolism and Pharmacokinetics Graeme has worked in the areas of Drug Safety and Medical services
For Pharmacovigilance and QA personnel, this course aims to demonstrate what the new guidances allow in terms of pharmacovigilance activities that can be relaxed during COVID and how to achieve these exemptions while achieving compliance and noting any deviations to existing processes and training.
Periodic reporting
Expedited reporting
What the EU Regulations are for COVID pharmacovigilance
Speaker:
With a first degree in Biochemistry & Pharmacology and a PhD focussing on drug metabolism and Pharmacokinetics Graeme has worked in the areas of Drug Safety and Medical services
Other CFPs
- Non-conforming Materials in a Medical Device Company – dealing with in-house to field issues LiveWebinar
- Managing complex boundary and dual relationship issues in behavioral health: Ethical and risk management challenges
- 12th EAI International Conference on Digital Forensics & Cyber Crime
- “It Smells and It’s Making Me Sick: Employer Responsibility Around Fragrance and Odor Sensitivity and Workplace Accommodation”
- Latest Webinar on Form 941 update 2021
Last modified: 2021-03-27 22:06:43